...
首页> 外文期刊>Anti-infective agents >In Silico (3D-QSAR) Designed, Study, Synthesis and Anti-tubercular Evaluation of Pyrazolo-Pyrimidine Derivatives | Bentham Science
【24h】

In Silico (3D-QSAR) Designed, Study, Synthesis and Anti-tubercular Evaluation of Pyrazolo-Pyrimidine Derivatives | Bentham Science

机译:在Silico(3D-QSAR)设计,研究,合成和抗结核评价吡唑氟吡啶胺衍生物| Bentham Science.

获取原文
获取原文并翻译 | 示例
           

摘要

A 3D-QSAR study based on CoMFA and CoMSIA was performed onthese pyrazole-pyrimidine derivatives to correlate their chemical structures with the observed activityagainst M. tuberculosis.Objectives: The current research aimed to synthesize and evaluateed pyrazole-pyrimidine basedantitubercular agents by an in vitro microbial study based on our previously reported 3D-QSAR.Methods: The designed molecules were synthesised via chalcone intermediate and cyclisation usingguanidine and urea. The molecules were then characterized by various spectroscopic methodslike IR, MASS, 1H-NMR, 13C-NMR and in vitro evaluation against M. tuberculosis H37Rv. Theywere further evaluated under anaerobic condition and their intracellular assay was studied. Thecompounds were further examined for cytotoxicity towards eukaryotic cells.Results: Compounds 3a, 3c and 3i were found to be the most effective against M. tuberculosisH37Rv, with IC50 of 16μM, 13μM and 15μM, respectively.Conclusion: The designed strategy, to enhance the antitubercular activity against M. tuberculosisH37Rv, was proved fruitful. On considering the overall data, the promising results would be usefulto design the next target with improved efficacy and potency of compounds for further medicinalimportance.
机译:None

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号